Search

Phosphorous-doped silica optical fibres with a core diameter of 4 µm were tested in X-ray and proton fields for application in cancer therapy dosimetry. Specifically, the radiation-induced attenuation was investigated in terms of linearity in deposited dose in 15 MV and 6 MV photons and 74 MeV protons, as well as Bragg-peak detection along the proton track. Fibres were found to demonstrate linear relative dose response in both radiation modalities, but possible saturation did occur at the high linear energy transfer of the Bragg peak. This demonstrates the possibility to use these fibres as a relative dosimeter for radiation therapy applications.

Optical fibres are gaining popularity for relative dosimetry in proton therapy due to their spatial resolution and ability for near real-time acquisition. For FLASH proton therapy, these fibres need to handle higher dose rates and larger doses than for conventional proton dose rates. We developed a multi-point fibre sensor embedded in a 3D-printed phantom which can measure the profile of a FLASH proton beam. Seven PMMA fibres of 1 mm diameter were embedded in a custom 3D-printed plastic phantom of the same density as the fibres. The phantom was placed in a proton beam with FLASH dose rates at the TRIUMF Proton Therapy Research Centre (PTRC). The sensor was exposed to different proton energies, 13.5 MeV, 19 MeV and 40.4 MeV, achieved by adding PMMA bolus in front of the phantom and three different beam currents, varying the dose rates from 7.5 to 101 Gy/s. The array was able to record beam profiles in both transverse and axial directions in relative agreement with measurements from EBT-XD radiochromic films (transverse) and Monte Carlo simulations (axial). A decrease in light output over time was observed, which might be caused by radiation damage in the matrix of the fibre and characterised by an exponential decay function. [ABSTRACT FROM AUTHOR]

As the technology to deliver precise and very high radiotherapeutic doses with narrow margins grows to better serve patients with complex radiotherapeutic needs, so does the need for sensors and sensor systems that can reliably deliver multi-point dose monitoring and dosimetry for enhanced safety and access. To address this need, we investigated a novel five-point scintillator system for simultaneously sampling points across a 74 MeV proton beam with a Hamamatsu 16-channel MPPC array. We studied the response across beam widths from 25 mm down to 5 mm in diameter and in multiple depths to observe beam penumbrae and output factors as well as depth–dose. We found through comparison to ionization chambers and radiochromic film that the array is capable of measurements accurate to within 8% in the centre of proton beams from 5 to 25 mm in diameter, and within 2% at 3.5 cm depth in water. The results from three trials are repeatable after calibration to within <1%. Overall, the five optical fibre sensor system shows promise as a fast, multipoint relative dosimetry system. [ABSTRACT FROM AUTHOR]

In recent years, proton therapy has gained importance as a cancer treatment modality due to its conformality with the tumor and the sparing of healthy tissue. However, in the interaction of the protons with the beam line elements and patient tissues, potentially harmful secondary neutrons are always generated. To ensure that this neutron dose is as low as possible, treatment plans could be created to also account for and minimize the neutron dose. To monitor such a treatment plan, a compact, easy to use, and inexpensive dosimeter must be developed that not only measures the physical dose, but which can also distinguish between proton and neutron contributions. To that end, plastic optical fibers with scintillation materials (Gd2O2S:Tb, Gd2O2S:Eu, and YVO4:Eu) were irradiated with protons and neutrons. It was confirmed that sensors with different scintillation materials have different sensitivities to protons and neutrons. A combination of these three scintillators can be used to build a detector array to create a biological dosimeter. [ABSTRACT FROM AUTHOR]

The TRIUMF particle accelerator center in Vancouver, British Columbia, Canada houses a proton therapy beam line formerly used for the treatment of ocular cancer. This existing Proton Therapy Research Centre (PTRC) was upgraded to deliver protons at ultra-high dose rates which would be required for FLASH radiotherapy treatments. A peak dose rate of 110 Gy/s over an area of 20 mm 2 was delivered at a beam energy of 21 MeV. This was achieved by degrading the cyclotron extracted beam energy of 70 MeV using polymethyl methacrylate (PMMA) plates. In addition, a fast, versatile and reliable method for producing static ridge filters has been developed to spread the proton beam to the entirety of the target axially (i.e., in depth). FLASH dose rates were maintained with a spread-out Bragg peak of 0.5 cm. [ABSTRACT FROM AUTHOR]